Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Knowledge capital in biotechnology industry: impacts on Canadian firm performance

Knowledge capital in biotechnology industry: impacts on Canadian firm performance Knowledge has become the main driver of economic growth. This is true both at the level of the macro-economy, where emerging countries make efforts to capture knowledge from more advanced countries and at the level of the firm, as companies make efforts to acquire complementary knowledge from other firms. The specific types of knowledge associated with performance differ from one industry to another, and on company maturity. A number of studies demonstrated that biotechnology performance and the geographical concentration of US firms are related to the recruitment of star researchers. This paper confirms these results for Canadian companies and goes further in accounting for the specific roles played by these highly productive university researchers and their impact on the performance of biotechnology enterprises. This discovery points to a new stage in the birth of biotechnology companies, and is associated with the selection of venture capitalists and major pharmaceutical companies who finance these specialised biotechnology firms. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Journal of Knowledge-Based Development Inderscience Publishers

Knowledge capital in biotechnology industry: impacts on Canadian firm performance

Loading next page...
 
/lp/inderscience-publishers/knowledge-capital-in-biotechnology-industry-impacts-on-canadian-firm-njtuINEu9y
Publisher
Inderscience Publishers
Copyright
Copyright © Inderscience Enterprises Ltd. All rights reserved
ISSN
2040-4468
eISSN
2040-4476
DOI
10.1504/IJKBD.2010.03259
Publisher site
See Article on Publisher Site

Abstract

Knowledge has become the main driver of economic growth. This is true both at the level of the macro-economy, where emerging countries make efforts to capture knowledge from more advanced countries and at the level of the firm, as companies make efforts to acquire complementary knowledge from other firms. The specific types of knowledge associated with performance differ from one industry to another, and on company maturity. A number of studies demonstrated that biotechnology performance and the geographical concentration of US firms are related to the recruitment of star researchers. This paper confirms these results for Canadian companies and goes further in accounting for the specific roles played by these highly productive university researchers and their impact on the performance of biotechnology enterprises. This discovery points to a new stage in the birth of biotechnology companies, and is associated with the selection of venture capitalists and major pharmaceutical companies who finance these specialised biotechnology firms.

Journal

International Journal of Knowledge-Based DevelopmentInderscience Publishers

Published: Jan 1, 2010

There are no references for this article.